Cargando…

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity

BACKGROUND: Palmitoylethanolamide (PEA) is a pleiotropic endogenous lipid mediator currently used as a “dietary food for special medical purposes” against neuropathic pain and neuro-inflammatory conditions. Several mechanisms underlie PEA actions, among which the “entourage” effect, consisting of PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrosino, Stefania, Schiano Moriello, Aniello, Verde, Roberta, Allarà, Marco, Imperatore, Roberta, Ligresti, Alessia, Mahmoud, Ali Mokhtar, Peritore, Alessio Filippo, Iannotti, Fabio Arturo, Di Marzo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933707/
https://www.ncbi.nlm.nih.gov/pubmed/31878942
http://dx.doi.org/10.1186/s12974-019-1671-5
_version_ 1783483263208128512
author Petrosino, Stefania
Schiano Moriello, Aniello
Verde, Roberta
Allarà, Marco
Imperatore, Roberta
Ligresti, Alessia
Mahmoud, Ali Mokhtar
Peritore, Alessio Filippo
Iannotti, Fabio Arturo
Di Marzo, Vincenzo
author_facet Petrosino, Stefania
Schiano Moriello, Aniello
Verde, Roberta
Allarà, Marco
Imperatore, Roberta
Ligresti, Alessia
Mahmoud, Ali Mokhtar
Peritore, Alessio Filippo
Iannotti, Fabio Arturo
Di Marzo, Vincenzo
author_sort Petrosino, Stefania
collection PubMed
description BACKGROUND: Palmitoylethanolamide (PEA) is a pleiotropic endogenous lipid mediator currently used as a “dietary food for special medical purposes” against neuropathic pain and neuro-inflammatory conditions. Several mechanisms underlie PEA actions, among which the “entourage” effect, consisting of PEA potentiation of endocannabinoid signaling at either cannabinoid receptors or transient receptor potential vanilloid type-1 (TRPV1) channels. Here, we report novel molecular mechanisms through which PEA controls mast cell degranulation and substance P (SP)-induced histamine release in rat basophilic leukemia (RBL-2H3) cells, a mast cell model. METHODS: RBL-2H3 cells stimulated with SP were treated with PEA in the presence and absence of a cannabinoid type-2 (CB2) receptor antagonist (AM630), or a diacylglycerol lipase (DAGL) enzyme inhibitor (OMDM188) to inhibit the biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG). The release of histamine was measured by ELISA and β-hexosaminidase release and toluidine blue staining were used as indices of degranulation. 2-AG levels were measured by LC-MS. The mRNA expression of proposed PEA targets (Cnr1, Cnr2, Trpv1, Ppara and Gpr55), and of PEA and endocannabinoid biosynthetic (Napepld, Dagla and Daglb) and catabolic (Faah, Naaa and Mgl) enzymes were also measured. The effects of PEA on the activity of DAGL-α or -β enzymes were assessed in COS-7 cells overexpressing the human recombinant enzyme or in RBL-2H3 cells, respectively. RESULTS: SP increased the number of degranulated RBL-2H3 cells and triggered the release of histamine. PEA counteracted these effects in a manner antagonized by AM630. PEA concomitantly increased the levels of 2-AG in SP-stimulated RBL-2H3 cells, and this effect was reversed by OMDM188. PEA significantly stimulated DAGL-α and -β activity and, consequently, 2-AG biosynthesis in cell-free systems. Co-treatment with PEA and 2-AG at per se ineffective concentrations downmodulated SP-induced release of histamine and degranulation, and this effect was reversed by OMDM188. CONCLUSIONS: Activation of CB2 underlies the inhibitory effects on SP-induced RBL-2H3 cell degranulation by PEA alone. We demonstrate for the first time that the effects in RBL-2H3 cells of PEA are due to the stimulation of 2-AG biosynthesis by DAGLs.
format Online
Article
Text
id pubmed-6933707
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69337072019-12-30 Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity Petrosino, Stefania Schiano Moriello, Aniello Verde, Roberta Allarà, Marco Imperatore, Roberta Ligresti, Alessia Mahmoud, Ali Mokhtar Peritore, Alessio Filippo Iannotti, Fabio Arturo Di Marzo, Vincenzo J Neuroinflammation Research BACKGROUND: Palmitoylethanolamide (PEA) is a pleiotropic endogenous lipid mediator currently used as a “dietary food for special medical purposes” against neuropathic pain and neuro-inflammatory conditions. Several mechanisms underlie PEA actions, among which the “entourage” effect, consisting of PEA potentiation of endocannabinoid signaling at either cannabinoid receptors or transient receptor potential vanilloid type-1 (TRPV1) channels. Here, we report novel molecular mechanisms through which PEA controls mast cell degranulation and substance P (SP)-induced histamine release in rat basophilic leukemia (RBL-2H3) cells, a mast cell model. METHODS: RBL-2H3 cells stimulated with SP were treated with PEA in the presence and absence of a cannabinoid type-2 (CB2) receptor antagonist (AM630), or a diacylglycerol lipase (DAGL) enzyme inhibitor (OMDM188) to inhibit the biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG). The release of histamine was measured by ELISA and β-hexosaminidase release and toluidine blue staining were used as indices of degranulation. 2-AG levels were measured by LC-MS. The mRNA expression of proposed PEA targets (Cnr1, Cnr2, Trpv1, Ppara and Gpr55), and of PEA and endocannabinoid biosynthetic (Napepld, Dagla and Daglb) and catabolic (Faah, Naaa and Mgl) enzymes were also measured. The effects of PEA on the activity of DAGL-α or -β enzymes were assessed in COS-7 cells overexpressing the human recombinant enzyme or in RBL-2H3 cells, respectively. RESULTS: SP increased the number of degranulated RBL-2H3 cells and triggered the release of histamine. PEA counteracted these effects in a manner antagonized by AM630. PEA concomitantly increased the levels of 2-AG in SP-stimulated RBL-2H3 cells, and this effect was reversed by OMDM188. PEA significantly stimulated DAGL-α and -β activity and, consequently, 2-AG biosynthesis in cell-free systems. Co-treatment with PEA and 2-AG at per se ineffective concentrations downmodulated SP-induced release of histamine and degranulation, and this effect was reversed by OMDM188. CONCLUSIONS: Activation of CB2 underlies the inhibitory effects on SP-induced RBL-2H3 cell degranulation by PEA alone. We demonstrate for the first time that the effects in RBL-2H3 cells of PEA are due to the stimulation of 2-AG biosynthesis by DAGLs. BioMed Central 2019-12-26 /pmc/articles/PMC6933707/ /pubmed/31878942 http://dx.doi.org/10.1186/s12974-019-1671-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Petrosino, Stefania
Schiano Moriello, Aniello
Verde, Roberta
Allarà, Marco
Imperatore, Roberta
Ligresti, Alessia
Mahmoud, Ali Mokhtar
Peritore, Alessio Filippo
Iannotti, Fabio Arturo
Di Marzo, Vincenzo
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
title Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
title_full Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
title_fullStr Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
title_full_unstemmed Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
title_short Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
title_sort palmitoylethanolamide counteracts substance p-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933707/
https://www.ncbi.nlm.nih.gov/pubmed/31878942
http://dx.doi.org/10.1186/s12974-019-1671-5
work_keys_str_mv AT petrosinostefania palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT schianomorielloaniello palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT verderoberta palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT allaramarco palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT imperatoreroberta palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT ligrestialessia palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT mahmoudalimokhtar palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT peritorealessiofilippo palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT iannottifabioarturo palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity
AT dimarzovincenzo palmitoylethanolamidecounteractssubstancepinducedmastcellactivationinvitrobystimulatingdiacylglycerollipaseactivity